1.

Higher numbers of T-bet(+) intratumoral lymphoid cells correlate with better survival in gastric cancer.

Chen LJ, Zheng X, Shen YP, Zhu YB, Li Q, Chen J, Xia R, Zhou SM, Wu CP, Zhang XG, Lu BF, Jiang JT.

Cancer Immunol Immunother. 2013 Mar;62(3):553-61. doi: 10.1007/s00262-012-1358-6. Epub 2012 Oct 23.

PMID:
23090288
2.

Higher Numbers of T-Bet+ Tumor-Infiltrating Lymphocytes Associate with Better Survival in Human Epithelial Ovarian Cancer.

Xu Y, Chen L, Xu B, Xiong Y, Yang M, Rui X, Shi L, Wu C, Jiang J, Lu B.

Cell Physiol Biochem. 2017;41(2):475-483. doi: 10.1159/000456600. Epub 2017 Jan 30.

3.

Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer.

Shen Z, Zhou S, Wang Y, Li RL, Zhong C, Liang C, Sun Y.

J Cancer Res Clin Oncol. 2010 Oct;136(10):1585-95. doi: 10.1007/s00432-010-0816-9. Epub 2010 Mar 11.

PMID:
20221835
4.

Increased tumor-infiltrating CD8(+)Foxp3(+) T lymphocytes are associated with tumor progression in human gastric cancer.

Peng LS, Zhuang Y, Shi Y, Zhao YL, Wang TT, Chen N, Cheng P, Liu T, Liu XF, Zhang JY, Zuo QF, Mao XH, Guo G, Lu DS, Yu PW, Zou QM.

Cancer Immunol Immunother. 2012 Nov;61(11):2183-92. doi: 10.1007/s00262-012-1277-6. Epub 2012 May 22.

PMID:
22729557
5.

Association of intra-tumoral infiltrating macrophages and regulatory T cells is an independent prognostic factor in gastric cancer after radical resection.

Wang B, Xu D, Yu X, Ding T, Rao H, Zhan Y, Zheng L, Li L.

Ann Surg Oncol. 2011 Sep;18(9):2585-93. doi: 10.1245/s10434-011-1609-3. Epub 2011 Feb 23.

PMID:
21347781
6.

Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers.

Ichihara F, Kono K, Takahashi A, Kawaida H, Sugai H, Fujii H.

Clin Cancer Res. 2003 Oct 1;9(12):4404-8.

7.

CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers.

Wakabayashi O, Yamazaki K, Oizumi S, Hommura F, Kinoshita I, Ogura S, Dosaka-Akita H, Nishimura M.

Cancer Sci. 2003 Nov;94(11):1003-9.

8.

T-cell-mediated tumor immune surveillance and expression of B7 co-inhibitory molecules in cancers of the upper gastrointestinal tract.

Lu B, Chen L, Liu L, Zhu Y, Wu C, Jiang J, Zhang X.

Immunol Res. 2011 Aug;50(2-3):269-75. doi: 10.1007/s12026-011-8227-9.

PMID:
21717068
9.

B7-H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinoma.

Chen LJ, Sun J, Wu HY, Zhou SM, Tan Y, Tan M, Shan BE, Lu BF, Zhang XG.

Cancer Immunol Immunother. 2011 Jul;60(7):1047-55. doi: 10.1007/s00262-011-1017-3. Epub 2011 Apr 26.

PMID:
21519829
10.

Decreased expression of interleukin-36α correlates with poor prognosis in hepatocellular carcinoma.

Pan QZ, Pan K, Zhao JJ, Chen JG, Li JJ, Lv L, Wang DD, Zheng HX, Jiang SS, Zhang XF, Xia JC.

Cancer Immunol Immunother. 2013 Nov;62(11):1675-85. doi: 10.1007/s00262-013-1471-1. Epub 2013 Sep 6.

PMID:
24061617
11.

Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers.

Kim KJ, Lee KS, Cho HJ, Kim YH, Yang HK, Kim WH, Kang GH.

Hum Pathol. 2014 Feb;45(2):285-93. doi: 10.1016/j.humpath.2013.09.004. Epub 2013 Dec 12.

PMID:
24331841
12.

Inflammation in gastric adenocarcinoma of the cardia: how do EBV infection, Her2 amplification and cancer progression influence tumor-infiltrating lymphocytes?

Haas M, Büttner M, Rau TT, Fietkau R, Grabenbauer GG, Distel LV.

Virchows Arch. 2011 Apr;458(4):403-11. doi: 10.1007/s00428-011-1058-1. Epub 2011 Feb 26.

PMID:
21359545
13.

Preoperative IL-2 immunotherapy enhances tumor infiltrating lymphocytes (TILs) in gastric cancer patients.

Romano F, Cesana G, Caprotti R, Bovo G, Uggeri F, Piacentini MG, Crippa S, Uggeri F.

Hepatogastroenterology. 2006 Jul-Aug;53(70):634-8.

PMID:
16995478
14.

Distribution of Th17 cells and FoxP3(+) regulatory T cells in tumor-infiltrating lymphocytes, tumor-draining lymph nodes and peripheral blood lymphocytes in patients with gastric cancer.

Maruyama T, Kono K, Mizukami Y, Kawaguchi Y, Mimura K, Watanabe M, Izawa S, Fujii H.

Cancer Sci. 2010 Sep;101(9):1947-54. doi: 10.1111/j.1349-7006.2010.01624.x.

15.

Tumor-infiltrating CD4+ Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer.

Iida T, Iwahashi M, Katsuda M, Ishida K, Nakamori M, Nakamura M, Naka T, Ojima T, Ueda K, Hayata K, Nakamura Y, Yamaue H.

Oncol Rep. 2011 May;25(5):1271-7. doi: 10.3892/or.2011.1201. Epub 2011 Mar 1.

PMID:
21369705
16.

CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection.

Yamada N, Oizumi S, Kikuchi E, Shinagawa N, Konishi-Sakakibara J, Ishimine A, Aoe K, Gemba K, Kishimoto T, Torigoe T, Nishimura M.

Cancer Immunol Immunother. 2010 Oct;59(10):1543-9. doi: 10.1007/s00262-010-0881-6. Epub 2010 Jun 22.

PMID:
20567822
17.

CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma.

Fukunaga A, Miyamoto M, Cho Y, Murakami S, Kawarada Y, Oshikiri T, Kato K, Kurokawa T, Suzuoki M, Nakakubo Y, Hiraoka K, Itoh T, Morikawa T, Okushiba S, Kondo S, Katoh H.

Pancreas. 2004 Jan;28(1):e26-31.

PMID:
14707745
18.

CD33⁺/p-STAT1⁺ double-positive cell as a prognostic factor for stage IIIa gastric cancer.

Dong J, Li J, Liu SM, Feng XY, Chen S, Chen YB, Zhang XS.

Med Oncol. 2013 Mar;30(1):442. doi: 10.1007/s12032-012-0442-2. Epub 2013 Jan 11.

19.

Critical role of spatial interaction between CD8⁺ and Foxp3⁺ cells in human gastric cancer: the distance matters.

Feichtenbeiner A, Haas M, Büttner M, Grabenbauer GG, Fietkau R, Distel LV.

Cancer Immunol Immunother. 2014 Feb;63(2):111-9. doi: 10.1007/s00262-013-1491-x. Epub 2013 Oct 30.

PMID:
24170095
20.

Supplemental Content

Loading ...
Support Center